US5093330A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Staurosporine derivatives substituted at methylamino nitrogen
Assignee: Novartis Corp
•
Filing: 1991-03-21
•
Granted: 1992-03-03
•
Expires: 2011-03-21
Abstract
Abstract N-substituted derivatives of staurosporine of the general formula [Stau]--N(CH.sub.3)--R (I) in which [Stau] represents a residue of the partial formula ##STR1## and R represents a hydrocarbyl radical R o or an acyl radical Ac, which radicals preferably have a maximum of 30 carbon atoms, and salts of compounds of the formula I having salt-forming properties, are distinguished as selective inhibitors of proteinkinase C. They are manufactured by conventional alkylation or acylation, respectively, of staurosporine.
Inventors
- 👤 Giorgio Caravatti
- 👤 Andreas Fredenhagen
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-28 09:37
CPC Classifications
C; C07; C07D; C07D498/00; C07D498/22
Claims Analysis
Total Claims: 13
Claim 1
Independent Claim
488 words
A N-substituted staurosporine compound of formula (I) [Stau]--N(CH.sub.3)--R in which [Stau] represents a residue of the formula ##STR15## and R represents an acyl radical selected from the group consisting of: (a) an acyl radical of the formula Z--C(═W)-- in which W is oxygen or sulfur, and Z represents C 1 -C 7 -alkyl, which is optionally substituted by halogen, by carboxy or by C 1 -C 4 -alkoxycarbonyl, or phenyl, pyridyl, furyl, thienyl, imidazolyl, quinolyl, isoquinolyl, benzofuranyl or benzimidazolyl, each of which is unsubstituted or substituted by C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy, halogen, nitro, trifluoromethyl, carboxy, C 1 -C 4 -alkoxycarbonyl, methylenedioxy, cyano or combinations thereof; (b) an acyl radical of the formula R b o --CO-- in which R b o represents hydrogen, a C 1 -C 19 -alkyl group or such an alkyl group substituted by amino, halogen and/or carboxy in the form of a free acid, a salt, a cyano group or a C 1 -C 4 -alkyl ester; (c) an acyl radical of the formula R o --SO 2 -- in which R o represents C 1 -C 7 -alkyl or phenyl, pyridyl, furyl, thienyl, imidazolyl, quinolyl, isoquinolyl, benzofuranyl or benzimidazolyl, each of which is unsubstituted or is substituted by C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy, halogen, nitro, trifluoromethyl, carboxy, C 1 -C 4 -alkoxycarbonyl, methylenedioxy, cyano or combinations thereof; (d) an acyl radical of the formula R o --O--CO in which R o represents C 1 -C 7 -alkyl or phenyl, pyridyl, furyl, thienyl, imidazolyl, quinolyl, isoquinolyl, benzofuranyl or benzimidazolyl, each of which is unsubstituted or is substituted by C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy, halogen, nitro, trifluoromethyl, carboxy, C 1 -C 4 -alkoxycarbonyl, methylenedioxy, cyano or combinations thereof; (e) an acyl radical of the formula ##STR16## in which W represents sulfur or oxygen, R 1 is hydrogen and R 2 represents C 1 -C 7 -alkyl, C 3 -C 7 -alkenyl or phenyl, pyridyl, furyl, thienyl, imidazolyl, quinolyl, isoquinolyl, benzofuranyl or benzimidazolyl, each of which is unsubstituted or is substituted by C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy, halogen, nitro, trifluoromethyl, carboxy, C 1 -C 4 -alkoxycarbonyl, methylenedioxy, cyano or combinations thereof; (f) an acyl radical of a naturally occurring α-amino acid of the L series; (g) an acyl radical of a naturally occurring α-amino acid of the L-series wherein the α-amino group is protected by an amino-protecting group, and when said α-amino acid contains a hydroxy radical, said hydroxy radical is either unprotected or protected by a hydroxy-protecting group and when said α-amino acid contains a carboxy group, said carboxy group is either unprotected or esterified by a lower alkanol or a phenyl-lower alkanol; and (h) an acyl radical of a naturally occuring α-amino acid of the L-series which carries a hydroxy radical that is protected by a hydroxy-protecting group and pharmaceutically acceptable salts thereof.
Claim 2
Dependent Claim
488 words
A N-substituted staurosporine compound of formula (I) [Stau]--N(CH.sub.3)--R in which [Stau] represents a residue of the formula ##STR15## and R represents an acyl radical selected from the group consisting of: (a) an acyl radical of the formula Z--C(═W)-- in which W is oxygen or sulfur, and Z represents C 1 -C 7 -alkyl, which is optionally substituted by halogen, by carboxy or by C 1 -C 4 -alkoxycarbonyl, or phenyl, pyridyl, furyl, thienyl, imidazolyl, quinolyl, isoquinolyl, benzofuranyl or benzimidazolyl, each of which is unsubstituted or substituted by C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy, halogen, nitro, trifluoromethyl, carboxy, C 1 -C 4 -alkoxycarbonyl, methylenedioxy, cyano or combinations thereof; (b) an acyl radical of the formula R b o --CO-- in which R b o represents hydrogen, a C 1 -C 19 -alkyl group or such an alkyl group substituted by amino, halogen and/or carboxy in the form of a free acid, a salt, a cyano group or a C 1 -C 4 -alkyl ester; (c) an acyl radical of the formula R o --SO 2 -- in which R o represents C 1 -C 7 -alkyl or phenyl, pyridyl, furyl, thienyl, imidazolyl, quinolyl, isoquinolyl, benzofuranyl or benzimidazolyl, each of which is unsubstituted or is substituted by C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy, halogen, nitro, trifluoromethyl, carboxy, C 1 -C 4 -alkoxycarbonyl, methylenedioxy, cyano or combinations thereof; (d) an acyl radical of the formula R o --O--CO in which R o represents C 1 -C 7 -alkyl or phenyl, pyridyl, furyl, thienyl, imidazolyl, quinolyl, isoquinolyl, benzofuranyl or benzimidazolyl, each of which is unsubstituted or is substituted by C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy, halogen, nitro, trifluoromethyl, carboxy, C 1 -C 4 -alkoxycarbonyl, methylenedioxy, cyano or combinations thereof; (e) an acyl radical of the formula ##STR16## in which W represents sulfur or oxygen, R 1 is hydrogen and R 2 represents C 1 -C 7 -alkyl, C 3 -C 7 -alkenyl or phenyl, pyridyl, furyl, thienyl, imidazolyl, quinolyl, isoquinolyl, benzofuranyl or benzimidazolyl, each of which is unsubstituted or is substituted by C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy, halogen, nitro, trifluoromethyl, carboxy, C 1 -C 4 -alkoxycarbonyl, methylenedioxy, cyano or combinations thereof; (f) an acyl radical of a naturally occurring α-amino acid of the L series; (g) an acyl radical of a naturally occurring α-amino acid of the L-series wherein the α-amino group is protected by an amino-protecting group, and when said α-amino acid contains a hydroxy radical, said hydroxy radical is either unprotected or protected by a hydroxy-protecting group and when said α-amino acid contains a carboxy group, said carboxy group is either unprotected or esterified by a lower alkanol or a phenyl-lower alkanol; and (h) an acyl radical of a naturally occuring α-amino acid of the L-series which carries a hydroxy radical that is protected by a hydroxy-protecting group and pharmaceutically acceptable salts thereof.
Claim 3
Dependent Claim
74 words
A compound according to claim 1 in which R represents an acyl radical of the formula Z--C(═W)-- in which W is oxygen and Z represents C 1 -C 7 -alkyl, which is optionally substituted by halogen, by carboxy or by C 1 -C 4 -alkoxycarbonyl, or represents phenyl, which is unsubstituted or substituted by C 1 -C 4 -alkyl, C 1 -C 4 -alkoxy, halogen, nitro, trifluoromethyl, carboxy, or C 1 -C 4 -alkoxycarbonyl.
Claim 4
Dependent Claim
45 words
A N-substituted staurosporine compound of formula (I) [Stau]--N(CH.sub.3)--R in which [Stau] represents a residue of the formula ##STR17## and R is derived from an α-amino acid selected from glycine, phenylglycine, alanine, phenylalanine, proline, leucine, isoleucine, tyrosine, valine, arginine, histidine, glutamic acid, aspartic acid and asparagine.
Claim 5
Dependent Claim
45 words
A N-substituted staurosporine compound of formula (I) [Stau]--N(CH.sub.3)--R in which [Stau] represents a residue of the formula ##STR17## and R is derived from an α-amino acid selected from glycine, phenylglycine, alanine, phenylalanine, proline, leucine, isoleucine, tyrosine, valine, arginine, histidine, glutamic acid, aspartic acid and asparagine.
Claim 6
Dependent Claim
1 words
N-(N-tert.-butoxycarbonylaminoacetyl)-staurosporine.
Claim 7
Dependent Claim
1 words
N-(N-tert.-butoxycarbonylaminoacetyl)-staurosporine.
Claim 8
Dependent Claim
15 words
A compound according to claim 1 selected from the group consisting of N-trifluoracetyl-staurosporine, and N-phenylcarbamoyl-staurosporine.
Claim 9
Dependent Claim
31 words
A pharmaceutical composition containing as active ingredient a pharmaceutically effective proteinkinase C inhibiting amount of at least one of the compounds defined in claim 1 together with a pharmaceutically acceptable carrier.
Claim 10
Dependent Claim
5 words
N-(3-carboxypropionyl)-staurosporine according to claim 1.
Claim 11
Dependent Claim
5 words
N-benzoyl-staurosporine according to claim 1.
Claim 12
Dependent Claim
5 words
N-methylaminothiocarbonyl-staurosporine according to claim 1.
Claim 13
Dependent Claim
21 words
A compound according to claim 1 selected from the group consisting of N-(3-Nitrobenzoyl)-staurosporine, N-(3-Fluorobenzoyl)-staurosporine, N-tert.-Butoxycarbonyl-staurosporine, N-(4-Carboxybenzoyl-staurosporine sodium salt, N-(3,5-Dinitrobenzoyl)-staurosporine, and N-(2-Aminoacetyl)-staurosporine.
References Cited (Backward Citations)
US4107297A
Cited
US4735939A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1995-03-03 | 1995-09-02 | 1996-03-03 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1999-03-03 | 1999-09-02 | 2000-03-03 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2003-03-03 | 2003-09-02 | 2004-03-03 | $7700.00 | Window Closed / Lapsed |